26 April 2020 - Medicines Australia has today reiterated the critical need for continued and transparent collaboration to support the ongoing and responsible management of Australia’s vital medicines supplies and proposes a ‘Five Critical Medicine Supply Priorities’ to enhance and extend supply processes in place.
“It is our priority, to ensure every Australian has access to their vital medicines across the nation during these challenging times – for those fighting COVID-19 in our hospitals and those in the community living with chronic and ongoing health conditions,” said Elizabeth de Somer, CEO Medicines Australia.
“We have been deeply concerned to hear reports of patients being unable to access their brands of medicines during this crisis. We want to reassure patients their medicines are our first priority and we are working extremely closely with Government and those involved in Australia’s medicine supply chain to do everything we can to manage our supplies – it’s our 24×7 focus to identify, manage and mitigate potential shortages,” Ms de Somer adds.